Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2020-10-07 2020-09-03
Drug Identification Number 02423766 02423766
Brand name MIDAZOLAM INJECTION MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM MIDAZOLAM
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MIDAZOLAM MIDAZOLAM
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 1ML VIALS 10 x 1ML VIALS
ATC code N05CD N05CD
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-09-25 2020-09-25
Actual start date
Estimated end date Unknown
Actual end date 2020-10-07
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Item has been discontinued. 5mg vial is available
Health Canada comments